Contact us for your 10% discount.
Positioned as the leading platform for high-level dialogue in the region, Biosimilars LatAm – Brazil 2026 brings together senior decision-makers from across the pharmaceutical ecosystem — including regulators, manufacturers, investors, and solution providers — to shape the future of biosimilars in Latin America.
Key objectives:
- Advance regulatory harmonization and reliance models across LATAM.
- Strengthen sustainable market access and procurement frameworks.
- Build trust through pharmacovigilance, RWE, and traceability.
- Accelerate local manufacturing and tech transfer capabilities.
- Enable partnerships and business matchmaking opportunities.
- Identify future pipeline and investment opportunities (2027–2030).
